In a hypertensive emergency with signs of end-organ damage, which agent is most appropriate for immediate blood pressure reduction?

• A. Nifedipine
• B. Labetalol
• C. Hydralazine
• D. Enalapril

Answer: (B)

In a hypertensive emergency with end-organ damage, the priority is to lower blood pressure quickly but in a controlled, titratable way to prevent further organ injury while preserving cerebral and coronary perfusion. An IV agent that provides rapid, dose-adjustable reduction with balanced effects on vascular resistance and heart rate is ideal. Labetalol fits this role because it blocks both alpha-1 and beta receptors. This combination lowers systemic vascular resistance without causing a sharp drop in heart rate or cardiac output, reducing the risk of hypoperfusion and avoiding reflex tachycardia. Its onset is rapid, and clinicians can titrate the dose to achieve a safe BP level within minutes, making it a preferred first-line choice in many hypertensive emergencies.

Nifedipine, especially the short-acting form, can cause an unpredictable and precipitous drop in BP with reflex tachycardia, potentially worsening ischemia. Hydralazine can lead to tachycardia, fluid retention, and an unpredictable response, making rapid titration harder. Enalaprilat (IV ACE inhibitor) acts more slowly and can cause first-dose hypotension in some patients, with less predictable immediate control. Thus, labetalol offers the most reliable, controllable control of BP in this urgent setting.